CELGENE
Celgene Corporation is a global integrated biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases in patients with limited treatment options. There are hundreds of clinical trials at major medical centers evaluating compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including mult... iple myeloma (MM), myelodysplastic syndromes (MDS), chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), pancreatic cancer, non-small lung cancer and melanoma. In addition, several compounds are being evaluated as therapies for serious inflammatory diseases such as psoriasis and psoriatic arthritis.
CELGENE
Industry:
Biotechnology Medical
Founded:
1986-01-01
Address:
Summit, New Jersey, United States
Country:
United States
Website Url:
http://www.bms.com
Total Employee:
10001+
Status:
Active
Contact:
+1-908-673-9000
Technology used in webpage:
Viewport Meta Font Awesome Domain Not Resolving Mobile Non Scaleable Content Nginx IPv6 Cloudflare YouTube Cloudflare Hosting Cloudflare SSL
Similar Organizations
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Current Advisors List
Board_member
2016-03-01
Board_member
2015-10-01
Board_member
2007-06-01
Board_member
2009-12-01
Board_member
2015-04-14
Board_member
2016-02-01
Board_member
2012-01-20
Board_member
2007-08-01
Current Employees Featured
Gerald Masoudi Executive Vice President, General Counsel and Corporate Secretary @ Celgene
Executive Vice President, General Counsel and Corporate Secretary
Angus Grant Corporate Vice President, Business Development @ Celgene
Corporate Vice President, Business Development
Mark Alles Chief Executive Officer @ Celgene
Chief Executive Officer
2016-03-01
Keith Usiskin Executive Director @ Celgene
Executive Director
Jacqualyn Fouse President and Chief Operating Officer @ Celgene
President and Chief Operating Officer
2016-03-01
Chris Wallace Senior Director and Global Logistics Operations @ Celgene
Senior Director and Global Logistics Operations
Robert M. Hershberg Executive Vice President, Head of Business Development and Global Alliances @ Celgene
Executive Vice President, Head of Business Development and Global Alliances
2017-04-01
Richard S. Lev Attorney @ Celgene
Attorney
David Weinstein Director Pricing and Market Access @ Celgene
Director Pricing and Market Access
Jerome Zeldis CEO of Celgene Global Health @ Celgene
CEO of Celgene Global Health
1997-01-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-01-22 | Juno Therapeutics | Juno Therapeutics acquired by Celgene | 9 B USD |
| 2018-01-07 | Impact Biomedicines | Impact Biomedicines acquired by Celgene | N/A |
| 2017-01-26 | Delinia | Delinia acquired by Celgene | 300 M USD |
| 2017-01-10 | Anokion | Anokion acquired by Celgene | 45 M USD |
| 2016-12-02 | Acetylon Pharmaceuticals | Acetylon Pharmaceuticals acquired by Celgene | N/A |
| 2016-10-17 | EngMab | EngMab acquired by Celgene | 600 M USD |
| 2015-07-14 | Receptos | Receptos acquired by Celgene | 7.32 B USD |
| 2015-06-09 | Lycera | Lycera acquired by Celgene | N/A |
| 2015-04-27 | Quanticel Pharmaceuticals | Quanticel Pharmaceuticals acquired by Celgene | 485 M USD |
| 2012-01-26 | Avila Therapeutics | Avila Therapeutics acquired by Celgene | 350 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-10-15 | Cyteir Therapeutics | Celgene investment in Series B - Cyteir Therapeutics | 40.2 M USD |
| 2019-09-11 | Anokion | Celgene investment in Series B - Anokion | 40 M USD |
| 2019-09-05 | immatics biotechnologies | Celgene investment in Venture Round - immatics biotechnologies | 75 M USD |
| 2019-08-21 | Oncorus | Celgene investment in Series B - Oncorus | 79.5 M USD |
| 2019-08-06 | Cleave Therapeutics | Celgene investment in Series C - Cleave Therapeutics | 12 M USD |
| 2019-07-09 | GNS Healthcare | Celgene investment in Series D - GNS Healthcare | 23 M USD |
| 2019-04-30 | Vividion Therapeutics | Celgene investment in Series B - Vividion Therapeutics | 82 M USD |
| 2019-04-18 | Arrakis Therapeutics | Celgene investment in Series B - Arrakis Therapeutics | 75 M USD |
| 2019-02-07 | HiberCell | Celgene investment in Series A - HiberCell | 60.75 M USD |
| 2019-01-08 | Biond Biologics | Celgene investment in Series B - Biond Biologics | 17 M USD |
Official Site Inspections
http://www.bms.com
- Host name: 45.60.150.161
- IP address: 45.60.150.161
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Celgene"
Bristol Myers Squibb - Wikipedia
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company.Headquartered …See details»
About us - Bristol Myers Squibb
BMS is addressing some of the most complex diseases of our time, and our legacy in cancer, HIV and cardiovascular gives us confidence that we will continue rising to each challenge. PATIENT-CENTRIC. Our global employees …See details»
Our leadership team - Bristol Myers Squibb
Meet the executive leaders at Bristol Myers Squibb who are not only responsible for day-to-day operations, but are also innovators in the biotech industry committed to patients, customers, employees, community and stockholders.See details»
Bristol Myers Squibb - Login - myBMS
Bristol Myers Squibb provides a platform for employees to access various services and resources.See details»
Bristol Myers Squibb Management Team | Org Chart
Bristol Myers Squibb employs 38,612 employees. The Bristol Myers Squibb management team includes Chris Boerner (Chief Executive Officer), Amanda Poole (Chief People Officer), and …See details»
Bristol-Myers Squibb Org Chart + Executive Team
Bristol-Myers Squibb Org Chart www.bms.com. has 187 executives and 24 subsidiaries +1 212 546 4000; Add an executive. Bristol-Myers Squibb (BMY) News . Anything missing? We search for you. ... Download your org chart in …See details»
Bristol-Myers Squibb - The Org
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases.See details»
Your Meaningful Career at Bristol Myers …
At Bristol Myers Squibb, your work helps people prevail over serious diseases. From the scientists behind the microscope to the analysts behind the data, everyone at BMS is working to …See details»
Bristol Myers-Squibb - Our mission and our …
Our mission. To discover, develop and deliver innovative medicines that help patients prevail over serious diseases. our Commitment. To our patients and customers, employees, global communities, shareholders, environment and …See details»
Bristol Myers Squibb - Global Health Progress
Learn more about BMS. The Bristol Myers Squibb Foundation. The Bristol Myers Squibb Foundation, an independent charitable organization, focuses on communities most at risk of …See details»
2023 ESG Report - Bristol Myers Squibb
“BMS has long been committed to corporate responsibility, and our refined ESG strategy is the result of the commitment by the entire organization to advance our sustainability. Together, we …See details»
Bristol Myers-Squibb - People - globalcitizens.bms.com
IN 2015 BMS EMPLOYEES VOLUNTEERED 7,751 HOURS. $4.2 MILLION BMS MATCHING GIFTS OVER THE PAST 2 YEARS. IN 2015 3,707 UNIQUE ORGANIZATIONS WERE …See details»
5 Key Insights on BMS' Patient-Centric Culture from VP Jamaal …
Jan 29, 2025 Taking a deep dive into our culture, we sat down with Jamaal Sebastian-Barnes, Vice President of Talent and Culture. Learn what drew him to BMS, why he finds our culture …See details»
Our mission, vision, values and commitment - Bristol Myers Squibb
Our commitment. To our patients and customers, employees, global communities, shareholders, environment and other stakeholders, we promise to act on our belief that the priceless …See details»
Learn Why Two Science Leaders Who Left BMS Were Inspired to …
Dec 19, 2024 BMS’ panel style interview made a major impression on her and fueled her desire to join the company. “The conversation around the table–the level of scientific discussion and …See details»
Corporate governance and management - Bristol Myers Squibb
T he Bristol Myers Squibb mission and commitment - the company's statement of values and principles that guides all of our activities - commits us to the highest standard of moral and …See details»
Our leadership - Bristol Myers Squibb
Working at BMS Contact us Related links. Global Patient Week. Our technologies. Our history. Our locations. The Bristol Myers Squibb Foundation. Resource groups. Our positions. …See details»
People and business resource groups - Bristol Myers Squibb
Black Organization for Leadership and Development (BOLD) Advance a diverse and inclusive environment where employees can show up BOLDly as their authentic selves, thrive …See details»
Environmental stewardship position statement - Bristol Myers …
BMS procurement brings critical goods and services from the best suppliers for the research and development of our medicines. We do so by building relationships with our suppliers based on …See details»
Working at Bristol-Myers Squibb - Zippia
Www.bms.com. Organization Type. Public. CEO. Giovanni Caforio. Social Media. Bristol Myers Squibb is a pharmaceutical company focusing on discovery, development, and distribution of …See details»